Year archive

Oncology Institute, Inc. — 2023 filings

All 69 regulatory filings released by Oncology Institute, Inc. (TOI) in 2023, sourced directly from the official regulator.

69 Filings

2023 Period

2023 filings (69)

Filing	Released	Lang
FORM 4 Director's Dealing	2023-12-28	English
FORM 4 Director's Dealing	2023-12-28	English
FORM 4 Director's Dealing	2023-12-28	English
FORM 4 Director's Dealing	2023-12-28	English
FORM 4 Director's Dealing	2023-12-28	English
FORM 4 Director's Dealing	2023-12-28	English
FORM 4 Director's Dealing	2023-12-28	English
FORM 4 Director's Dealing	2023-12-28	English
FORM 4 Director's Dealing	2023-12-18	English
FORM 4 Director's Dealing	2023-12-05	English
FORM 4 Director's Dealing	2023-11-23	English
FORM 4 Director's Dealing	2023-11-23	English
FORM 4 Director's Dealing	2023-11-23	English
FORM 4 Director's Dealing	2023-11-22	English
Regulatory Filings 2023 Regulatory Filings	2023-11-17	English
FORM 4 Director's Dealing	2023-11-16	English
FORM 4 Director's Dealing	2023-11-16	English
FORM 4 Director's Dealing	2023-11-16	English
Regulatory Filings 2023 Regulatory Filings	2023-11-13	English
10-Q Interim / Quarterly Report Q3 2023	2023-11-08	English
8-K Regulatory Filings	2023-11-08	English
8-K Regulatory Filings	2023-09-18	English
FORM 3 Director's Dealing	2023-09-07	English
8-K Board/Management Information	2023-09-06	English
8-K Board/Management Information	2023-09-01	English
8-K Transaction in Own Shares	2023-08-30	English
8-K Investor Presentation	2023-08-10	English
10-Q Interim / Quarterly Report Q2 2023	2023-08-09	English
8-K Earnings Release	2023-08-09	English
Major Shareholding Notification 2023 Major Shareholding Notification	2023-07-10	English
8-K Declaration of Voting Results & Voting Rights Announcements	2023-06-17	English
FORM 8-K Capital/Financing Update	2023-06-15	English
DEFA14A Board/Management Information	2023-06-14	English
8-K/A Board/Management Information	2023-06-14	English
8-K Board/Management Information	2023-06-12	English
PRIMARY DOCUMENT Director's Dealing	2023-05-25	English
8-K Board/Management Information	2023-05-22	English
10-Q Interim / Quarterly Report Q1 2023	2023-05-10	English
8-K Earnings Release	2023-05-10	English
DEFA14A Proxy Solicitation & Information Statement	2023-04-28	English
DEF 14A Proxy Solicitation & Information Statement	2023-04-28	English
8-K Delisting Announcement	2023-04-27	English
SCHEDULE 13G/A Major Shareholding Notification	2023-04-03	English
8-K Regulatory Filings	2023-03-27	English
FORM 4 Director's Dealing	2023-03-22	English
FORM 4 Director's Dealing	2023-03-22	English
FORM 4 Director's Dealing	2023-03-22	English
FORM 4 Director's Dealing	2023-03-22	English
FORM 4 Director's Dealing	2023-03-22	English
FORM 4 Director's Dealing	2023-03-22	English
FORM 4 Director's Dealing	2023-03-22	English
FORM 4 Director's Dealing	2023-03-22	English
FORM 4 Director's Dealing	2023-03-22	English
FORM 4 Director's Dealing	2023-03-22	English
FORM 4 Director's Dealing	2023-03-22	English
FORM 4 Director's Dealing	2023-03-22	English
8-K/A Earnings Release	2023-03-17	English
10-K Annual Report FY 2022	2023-03-16	English
8-K Regulatory Filings	2023-03-09	English
424B3 Capital/Financing Update	2023-02-10	English
424B3 Capital/Financing Update	2023-02-10	English
Regulatory Filings 2023 Regulatory Filings	2023-02-10	English
Regulatory Filings 2023 Regulatory Filings	2023-02-10	English
Major Shareholding Notification 2023 Major Shareholding Notification	2023-02-09	English
POS AM Regulatory Filings	2023-01-28	English
POS AM Regulatory Filings	2023-01-28	English
SCHEDULE 13G/A Major Shareholding Notification	2023-01-10	English
424B3 Capital/Financing Update	2023-01-09	English
Regulatory Filings 2023 Regulatory Filings	2023-01-09	English